Data / Drug companies / Pantoprazole sodium
Pantoprazole sodium: 54 companies and 108 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Pantoprazole sodium is listed in the FDA National Drug Code Directory by 54 companies, with 108 products in commercial distribution. 97 of the products (89.8%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, delayed release; injection, powder, for solution; injection, powder, lyophilized, for solution, and the newest product started marketing on September 30, 2026.
The request: Get every company that lists pantoprazole sodium in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 54
- Products
- 108
- Generic (ANDA) products
- 97 (89.8%)
- Application numbers
- 28
- Routes
- Oral, Intravenous
- Brand names
- Protonix I.V., Protonix Delayed-Release
- openFDA record search
- api.fda.gov
Companies that list pantoprazole sodium
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Cardinal Health 107, LLC | 10 | tablet, delayed release; injection, powder, for solution | Generic drugs (ANDA) | September 14, 2026 |
| Advanced Rx of Tennessee, LLC | 6 | tablet, delayed release | Generic drugs (ANDA) | June 27, 2024 |
| Wyeth Pharmaceuticals LLC, a Subsidiary of Pfizer Inc. | 5 | tablet, delayed release; injection, powder, for solution | New drug applications (NDA) | May 1, 2013 |
| A-S Medication Solutions | 4 | tablet, delayed release | Generic drugs (ANDA) | September 28, 2012 |
| NuCare Pharmaceuticals,Inc. | 4 | tablet, delayed release | Generic drugs (ANDA) | September 28, 2012 |
| American Health Packaging | 3 | tablet, delayed release; for suspension | Generic drugs (ANDA) | August 1, 2023 |
| Bryant Ranch Prepack | 3 | tablet, delayed release | Generic drugs (ANDA) | September 28, 2012 |
| Major Pharmaceuticals | 3 | tablet, delayed release | Generic drugs (ANDA) | October 7, 2024 |
| NorthStar RxLLC | 3 | granule, delayed release; injection, powder, for solution | Generic drugs (ANDA) | March 1, 2026 |
| Remedyrepack Inc. | 3 | tablet, delayed release | Generic drugs (ANDA) | January 11, 2019 |
| Asclemed USA, Inc. | 2 | tablet, delayed release | Generic drugs (ANDA) | September 28, 2012 |
| Aurobindo Pharma Limited | 2 | tablet, delayed release | Generic drugs (ANDA) | September 28, 2012 |
| AvPAK | 2 | tablet, delayed release | Generic drugs (ANDA) | January 28, 2021 |
| Camber Pharmaceuticals, Inc. | 2 | granule, delayed release; injection, powder, for solution | Generic drugs (ANDA) | October 27, 2023 |
| Chartwell RX, LLC | 2 | tablet, delayed release | Generic drugs (ANDA) | January 20, 2011 |
| Coupler LLC | 2 | tablet, delayed release | Generic drugs (ANDA) | June 1, 2026 |
| Golden State Medical Supply, Inc. | 2 | tablet, delayed release | Generic drugs (ANDA) | January 20, 2011 |
| Granules Pharmaceuticals Inc. | 2 | tablet, delayed release | Generic drugs (ANDA) | April 12, 2024 |
| Hawaii Repack, Inc. | 2 | tablet, delayed release | Generic drugs (ANDA) | September 28, 2012 |
| Hikma Pharmaceuticals USA Inc. | 2 | injection, powder, lyophilized, for solution | New drug applications (NDA) | September 22, 2017 |
| Lannett Company, Inc. | 2 | tablet, delayed release | Generic drugs (ANDA) | January 20, 2011 |
| Meitheal Pharmaceuticals Inc. | 2 | injection, powder, for solution | Generic drugs (ANDA) | August 29, 2022 |
| Mylan Pharmaceuticals Inc. | 2 | tablet, delayed release | Generic drugs (ANDA) | January 19, 2011 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 2 | tablet, delayed release | Generic drugs (ANDA) | September 28, 2012 |
| Northwind Health Company, LLC | 2 | tablet, delayed release | Generic drugs (ANDA) | September 27, 2022 |
| QPharma, Inc. | 2 | tablet, delayed release | Generic drugs (ANDA) | September 28, 2012 |
| Rising Pharma Holdings, Inc. | 2 | tablet, delayed release | Generic drugs (ANDA) | March 12, 2025 |
| Sun Pharmaceutical Industries, Inc. | 2 | granule, delayed release; injection, powder, lyophilized, for solution | Generic drugs (ANDA) | July 1, 2020 |
| Torrent Pharmaceuticals Limited | 2 | tablet, delayed release | Generic drugs (ANDA) | January 20, 2011 |
| Unit Dose Solutions, Inc. | 2 | tablet, delayed release | Generic drugs (ANDA) | July 1, 2026 |
| Ajanta Pharma USA Inc. | 1 | for suspension | Generic drugs (ANDA) | February 9, 2023 |
| Aphena Pharma Solutions - Tennessee, LLC | 1 | tablet, delayed release | Generic drugs (ANDA) | January 20, 2011 |
| Aurobindo Pharma Limited | 1 | granule, delayed release | Generic drugs (ANDA) | March 31, 2025 |
| Avenacy, LLC | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | September 30, 2026 |
| Be Pharmaceuticals Inc. | 1 | injection, powder, for solution | Generic drugs (ANDA) | May 25, 2022 |
| Bryant Ranch Prepack | 1 | tablet, delayed release | Generic drugs (ANDA) | January 20, 2011 |
| Burel Pharmaceuticals, LLC | 1 | tablet, delayed release | Generic drugs (ANDA) | April 20, 2020 |
| Civica, Inc. | 1 | injection, powder, lyophilized, for solution | New drug applications (NDA) | June 1, 2025 |
| Devatis, Inc. | 1 | injection, powder, for solution | Generic drugs (ANDA) | August 1, 2025 |
| Edenbridge Pharmaceuticals LLC. | 1 | granule, delayed release | Generic drugs (ANDA) | June 16, 2023 |
| Eugia US LLC | 1 | injection, powder, for solution | Generic drugs (ANDA) | March 30, 2016 |
| Fresenius Kabi USA, LLC | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | August 1, 2024 |
| Gland Pharma Limited | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | May 18, 2022 |
| Mylan Institutional Inc. | 1 | tablet, delayed release | Generic drugs (ANDA) | February 23, 2011 |
| Novadoz Pharmaceuticals LLC | 1 | injection, powder, for solution | Generic drugs (ANDA) | May 19, 2022 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet, delayed release | Generic drugs (ANDA) | January 20, 2011 |
| Piramal Critical Care Inc | 1 | injection, powder, for solution | Generic drugs (ANDA) | October 10, 2023 |
| Proficient Rx LP | 1 | tablet, delayed release | Generic drugs (ANDA) | January 20, 2011 |
| Quality Care Products, LLC | 1 | tablet, delayed release | Generic drugs (ANDA) | July 18, 2023 |
| Redpharm Drug | 1 | tablet, delayed release | Generic drugs (ANDA) | September 28, 2012 |
| Safecor Health, LLC | 1 | tablet, delayed release | Generic drugs (ANDA) | March 13, 2026 |
| Sagent Pharmaceuticals | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | July 15, 2022 |
| Sandoz Inc | 1 | injection, powder, for solution | Generic drugs (ANDA) | January 26, 2026 |
| Sun Pharmaceutical Industries, Inc. | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | April 3, 2023 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, delayed release | 75 | 69.4% |
| Injection, powder, for solution | 15 | 13.9% |
| Injection, powder, lyophilized, for solution | 10 | 9.3% |
| Granule, delayed release | 6 | 5.6% |
| For suspension | 2 | 1.9% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 97 | 89.8% |
| New drug applications (NDA) | 11 | 10.2% |
Pharmacologic classes
| Class | Products |
|---|---|
| Proton Pump Inhibitor | 108 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.